Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

miRNAs and long noncoding RNAs as biomarkers in human diseases.

Van Roosbroeck K, Pollet J, Calin GA.

Expert Rev Mol Diagn. 2013 Mar;13(2):183-204. doi: 10.1586/erm.12.134. Review.

PMID:
23477558
2.

Non-coding RNAs in human disease.

Esteller M.

Nat Rev Genet. 2011 Nov 18;12(12):861-74. doi: 10.1038/nrg3074. Review.

PMID:
22094949
3.

Analytical aspects of microRNA in diagnostics: a review.

de Planell-Saguer M, Rodicio MC.

Anal Chim Acta. 2011 Aug 12;699(2):134-52. doi: 10.1016/j.aca.2011.05.025. Review.

PMID:
21704768
4.

Cardiovascular RNA interference therapy: the broadening tool and target spectrum.

Poller W, Tank J, Skurk C, Gast M.

Circ Res. 2013 Aug 16;113(5):588-602. doi: 10.1161/CIRCRESAHA.113.301056. Review.

5.

Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology.

Choudhuri S.

J Biochem Mol Toxicol. 2010 May-Jun;24(3):195-216. doi: 10.1002/jbt.20325. Review.

PMID:
20143452
6.

New meaning in the message: noncoding RNAs and their role in retinal development.

Rapicavoli NA, Blackshaw S.

Dev Dyn. 2009 Sep;238(9):2103-14. doi: 10.1002/dvdy.21844. Review.

7.

Noncoding RNAs in endocrine malignancy.

Kentwell J, Gundara JS, Sidhu SB.

Oncologist. 2014 May;19(5):483-91. doi: 10.1634/theoncologist.2013-0458. Review.

8.

Involvement of long noncoding RNAs in diseases affecting the central nervous system.

Pastori C, Wahlestedt C.

RNA Biol. 2012 Jun;9(6):860-70. doi: 10.4161/rna.20482. Review.

9.

Small non-coding RNAs in disease development and host-pathogen interactions.

Rederstorff M, Hüttenhofer A.

Curr Opin Mol Ther. 2010 Dec;12(6):684-94. Review.

PMID:
21154160
10.

Non-coding RNAs in Alzheimer's disease.

Tan L, Yu JT, Hu N, Tan L.

Mol Neurobiol. 2013 Feb;47(1):382-93. doi: 10.1007/s12035-012-8359-5. Review.

PMID:
23054683
11.

Noncoding RNAs in molecular characterization of cancer preneoplasia.

Wang W, Srivastava S.

Cancer Biomark. 2010;9(1-6):133-40. doi: 10.3233/CBM-2011-0179. Review.

PMID:
22112473
12.

MicroRNAs as biomarkers and therapeutic drugs in human cancer.

Osaki M, Takeshita F, Ochiya T.

Biomarkers. 2008 Nov;13(7):658-70. doi: 10.1080/13547500802646572 . Review.

PMID:
19096960
13.

MicroRNA as Biomarkers and Diagnostics.

Wang J, Chen J, Sen S.

J Cell Physiol. 2016 Jan;231(1):25-30. doi: 10.1002/jcp.25056. Review.

PMID:
26031493
14.

MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.

Wang Y, Liang Y, Lu Q.

Clin Genet. 2008 Oct;74(4):307-15. doi: 10.1111/j.1399-0004.2008.01075.x. Review.

PMID:
18713257
15.

Novel classes of non-coding RNAs and cancer.

Sana J, Faltejskova P, Svoboda M, Slaby O.

J Transl Med. 2012 May 21;10:103. doi: 10.1186/1479-5876-10-103. Review.

16.

The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.

Zeng L, Cui J, Wu H, Lu Q.

Autoimmunity. 2014 Nov;47(7):419-29. doi: 10.3109/08916934.2014.929667. Review.

PMID:
24953646
17.

Noncoding RNAs as novel biomarkers in prostate cancer.

Rönnau CG, Verhaegh GW, Luna-Velez MV, Schalken JA.

Biomed Res Int. 2014;2014:591703. doi: 10.1155/2014/591703. Review.

18.

Non-coding RNAs: regulators of disease.

Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS.

J Pathol. 2010 Jan;220(2):126-39. doi: 10.1002/path.2638. Review.

PMID:
19882673
19.

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C.

Int J Oncol. 2012 Dec;41(6):1897-912. doi: 10.3892/ijo.2012.1647. Review.

PMID:
23026890
20.

Dynamic nature of noncoding RNA regulation of adaptive immune response.

Curtale G, Citarella F.

Int J Mol Sci. 2013 Aug 22;14(9):17347-77. doi: 10.3390/ijms140917347. Review.

Items per page

Supplemental Content

Support Center